Invention Grant
- Patent Title: Monoclonal antibodies and diagnostic uses thereof
- Patent Title (中): 单克隆抗体及其诊断用途
-
Application No.: US14452372Application Date: 2014-08-05
-
Publication No.: US09410957B2Publication Date: 2016-08-09
- Inventor: Nathalie Kertesz , Sutao Zhu , Chih-Sheng Chiang
- Applicant: MannKind Corporation
- Applicant Address: US CA Valencia
- Assignee: MANNKIND CORPORATION
- Current Assignee: MANNKIND CORPORATION
- Current Assignee Address: US CA Valencia
- Agency: Hahn Loeser Parks LLP
- Agent Sheila R. Gibson
- Main IPC: C07K16/30
- IPC: C07K16/30 ; G01N33/574 ; C07K14/47 ; C07K16/18
Abstract:
The disclosure relates to antibodies to the preferentially expressed antigen in melanoma (PRAME), and the synovial sarcoma X breakpoint 2 (SSX-2) antigens, methods of use, and diagnostic kits thereof. In exemplary embodiments, the disclosure relates to monoclonal antibodies to specific epitopes of the PRAME and SSX-2 antigens and methods of using such antibodies.
Public/Granted literature
- US20150044704A1 MONOCLONAL ANTIBODIES AND DIAGNOSTIC USES THEREOF Public/Granted day:2015-02-12
Information query
